MCID: HYP056
MIFTS: 66

Hypoglycemia

Categories: Blood diseases, Endocrine diseases, Metabolic diseases

Aliases & Classifications for Hypoglycemia

MalaCards integrated aliases for Hypoglycemia:

Name: Hypoglycemia 12 74 29 54 6 42 43 15 71
Hypoglycaemia 12 15

Classifications:



External Ids:

Disease Ontology 12 DOID:9993
ICD9CM 34 251.2
MeSH 43 D007003
NCIt 49 C3126
SNOMED-CT 67 302866003
ICD10 32 E16.2
UMLS 71 C0020615

Summaries for Hypoglycemia

MedlinePlus : 42 Hypoglycemia means low blood glucose, or blood sugar. Your body needs glucose to have enough energy. After you eat, your blood absorbs glucose. If you eat more sugar than your body needs, your muscles, and liver store the extra. When your blood sugar begins to fall, a hormone tells your liver to release glucose. In most people, this raises blood sugar. If it doesn't, you have hypoglycemia, and your blood sugar can be dangerously low. Signs include Hunger Shakiness Dizziness Confusion Difficulty speaking Feeling anxious or weak In people with diabetes, hypoglycemia is often a side effect of diabetes medicines. Eating or drinking something with carbohydrates can help. If it happens often, your health care provider may need to change your treatment plan. You can also have low blood sugar without having diabetes. Causes include certain medicines or diseases, hormone or enzyme deficiencies, and tumors. Laboratory tests can help find the cause. The kind of treatment depends on why you have low blood sugar. NIH: National Institute of Diabetes and Digestive and Kidney Diseases

MalaCards based summary : Hypoglycemia, also known as hypoglycaemia, is related to hyperinsulinemic hypoglycemia, familial, 2 and hyperinsulinemic hypoglycemia, familial, 6, and has symptoms including sugar craving An important gene associated with Hypoglycemia is G6PC (Glucose-6-Phosphatase Catalytic Subunit), and among its related pathways/superpathways are Metabolism and Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.. The drugs lanreotide and Gliclazide have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and liver, and related phenotypes are Decreased viability and Decreased viability

Disease Ontology : 12 A glucose metabolism disease that is characterized by abnormally low levels of blood glucose.

Wikipedia : 74 Hypoglycemia, also known as low blood sugar, is a fall in blood sugar to levels below normal. This may... more...

Related Diseases for Hypoglycemia

Diseases related to Hypoglycemia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1111, show less)
# Related Disease Score Top Affiliating Genes
1 hyperinsulinemic hypoglycemia, familial, 2 35.2 KCNJ11 INS ABCC8
2 hyperinsulinemic hypoglycemia, familial, 6 34.9 SLC16A1 HADH GLUD1 GCK ABCC8
3 hyperinsulinemic hypoglycemia, familial, 7 34.9 SLC16A1 KCNJ11 HADH GLUD1 GCK ABCC8
4 hyperinsulinemic hypoglycemia 34.5 SLC16A1 KCNJ11 INSR INS HADH GLUD1
5 fasting hypoglycemia 34.3 INSR GYS2 GLUD1 CRH ACADM
6 glycogen storage disease type 0 33.7 GYS2 AGL
7 carnitine palmitoyltransferase ii deficiency, infantile 33.7 SLC25A20 HADH CPT2 CPT1A ACADVL ACADM
8 fructose-1,6-bisphosphatase deficiency 33.3 GCK GCG G6PC FBP1 ABCC8
9 carnitine palmitoyltransferase i deficiency 33.2 CPT2 CPT1A ACADVL ACADM
10 glycogen storage disease ia 33.2 INS GCG G6PC FBP1 AGL
11 carnitine-acylcarnitine translocase deficiency 33.2 SLC25A20 CPT2 CPT1A ACADVL
12 3-hydroxyacyl-coa dehydrogenase deficiency 33.0 HADH GLUD1 GCK ACADVL ACADM
13 acyl-coa dehydrogenase, very long-chain, deficiency of 33.0 SLC25A20 HADH CPT2 ACADVL ACADM
14 acyl-coa dehydrogenase, medium-chain, deficiency of 33.0 SLC25A20 HADH CPT2 ACADVL ACADM
15 multiple acyl-coa dehydrogenase deficiency 32.9 SLC25A20 HADH CPT2 ACADVL ACADM
16 hyperinsulinism 32.8 SLC16A1 KCNJ11 INSR INS HADH GLUD1
17 long-chain 3-hydroxyacyl-coa dehydrogenase deficiency 32.7 HADH ACADVL ACADM
18 carbonic anhydrase va deficiency, hyperammonemia due to 32.7 SLC25A20 GLUD1
19 mitochondrial trifunctional protein deficiency 32.7 SLC25A20 HADH CPT2 ACADVL ACADM
20 glycogen storage disease vi 32.6 GYS2 G6PC AGL
21 epiphyseal dysplasia, multiple, with early-onset diabetes mellitus 32.6 KCNJ11 INS ABCC8
22 carnitine deficiency, systemic primary 32.5 SLC25A20 HADH CPT2 ACADVL ACADM
23 acyl-coa dehydrogenase, short-chain, deficiency of 32.4 HADH CPT2 ACADVL ACADM
24 donohue syndrome 32.3 INSR INS GCK
25 insulinoma 32.1 INS GCK GCG ABCC8
26 hyperglycemia 32.0 KCNJ11 INSR INS GCK GCG G6PC
27 diabetes mellitus 31.6 KCNJ11 INSR INS GCK GCG G6PC
28 hypoglycemic coma 31.5 INS GCG
29 diabetes mellitus, ketosis-prone 31.5 KCNJ11 INS GCG ABCC8
30 gestational diabetes 31.3 KCNJ11 INSR INS GCK GCG ABCC8
31 insulin-like growth factor i 31.3 INSR INS AKT2
32 glycogen storage disease 31.2 INS GYS2 G6PC CPT2 AGL
33 maturity-onset diabetes of the young 31.1 KCNJ11 INS GCK GCG G6PC ABCC8
34 glucose intolerance 31.0 KCNJ11 INSR INS GCK GCG ABCC8
35 munchausen by proxy 30.8 KCNJ11 GCK ABCC8
36 maturity-onset diabetes of the young, type 3 30.8 KCNJ11 INS GCK ABCC8
37 diabetes mellitus, noninsulin-dependent 30.8 KCNJ11 INSR INS GCK GCG G6PC
38 asphyxia neonatorum 30.8 SLC16A1 KCNJ11 INS HADH ABCC8
39 monocarboxylate transporter 1 deficiency 30.7 SLC16A1 INS GLUD1
40 neonatal diabetes mellitus 30.7 KCNJ11 INS GCK GCG ABCC8
41 pituitary gland disease 30.7 INS GCG CRH
42 lipoid congenital adrenal hyperplasia 30.7 INS CRH ACADM
43 diabetes mellitus, permanent neonatal 4 30.7 KCNJ11 INS GCK ABCC8
44 monogenic diabetes 30.7 KCNJ11 INS GCK ABCC8
45 diabetes mellitus, permanent neonatal 1 30.6 KCNJ11 INS GCK ABCC8
46 transient neonatal diabetes mellitus 30.6 KCNJ11 INS GCK ABCC8
47 maple syrup urine disease 30.6 HADH GLUD1 ACADM
48 atrial standstill 1 30.6 SLC25A20 CPT2 AGL ACADVL
49 acute insulin response 30.5 KCNJ11 INS GCG ABCC8
50 3-methylcrotonyl-coa carboxylase deficiency 30.5 HADH ACADVL ACADM
51 maturity-onset diabetes of the young, type 2 30.5 KCNJ11 INS GCK GCG ABCC8
52 abdominal obesity-metabolic syndrome 1 30.4 INSR INS GCK GCG ACADM
53 spinocerebellar degeneration 30.4 GLUD1 CRH
54 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 30.4 CPT2 ACADVL
55 pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities 30.4 INSR INS
56 wolfram syndrome 30.3 KCNJ11 INS CRH
57 sheehan syndrome 30.3 INS CRH
58 body mass index quantitative trait locus 11 30.3 KCNJ11 INSR INS GCK GCG G6PC
59 fetal macrosomia 30.3 INSR INS
60 maturity-onset diabetes of the young, type 1 30.2 KCNJ11 INS GCK GCG ABCC8
61 hypothalamic disease 30.2 INS CRH
62 myopathy 30.2 SLC25A20 INSR INS HADH CPT2 AGL
63 glucose metabolism disease 30.2 KCNJ11 INS GCK GCG G6PC
64 myoglobinuria 30.1 HADH CPT2 ACADVL
65 carbohydrate metabolic disorder 30.1 KCNJ11 INS GCG G6PC AGL ABCC8
66 hyperinsulinemic hypoglycemia, familial, 1 12.8
67 hyperinsulinemic hypoglycemia, familial, 5 12.7
68 hypoglycemia, leucine-induced 12.7
69 hyperinsulinemic hypoglycemia, familial, 4 12.7
70 hyperinsulinemic hypoglycemia, familial, 3 12.7
71 hypoinsulinemic hypoglycemia with hemihypertrophy 12.6
72 immunodeficiency 59 and hypoglycemia 12.5
73 non-insulinoma pancreatogenous hypoglycemia syndrome 12.3
74 glycogen storage disease 0, liver 12.1
75 hirata disease 12.0
76 familial glucocorticoid deficiency 11.6
77 fructose intolerance, hereditary 11.6
78 3-hydroxy-3-methylglutaryl-coa lyase deficiency 11.6
79 diabetes mellitus, type i 11.6
80 brittle diabetes 11.6
81 glycogen storage disease iii 11.6
82 beckwith-wiedemann syndrome 11.5
83 insulinomatosis and diabetes mellitus 11.4
84 phosphorylase kinase deficiency 11.4
85 galactosemia i 11.4
86 congenital disorder of glycosylation, type ib 11.4
87 glucocorticoid deficiency 1 11.4
88 phosphoenolpyruvate carboxykinase deficiency, cytosolic 11.4
89 metastatic insulinoma 11.3
90 premature ovarian failure 7 11.3
91 acth deficiency, isolated 11.3
92 renal glucosuria 11.3
93 congenital disorder of glycosylation, type in 11.3
94 septooptic dysplasia 11.3
95 achalasia-addisonianism-alacrima syndrome 11.3
96 mitochondrial dna depletion syndrome 4a 11.3
97 propionic acidemia 11.3
98 aromatic l-amino acid decarboxylase deficiency 11.3
99 diabetes mellitus, insulin-resistant, with acanthosis nigricans 11.3
100 riboflavin deficiency 11.3
101 combined oxidative phosphorylation deficiency 36 11.3
102 mitochondrial complex iii deficiency 11.3
103 pepck 1 deficiency 11.3
104 pituitary stalk interruption syndrome 11.3
105 mitochondrial dna depletion syndrome 3 11.2
106 malonyl-coa decarboxylase deficiency 11.2
107 timothy syndrome 11.2
108 glucocorticoid deficiency 2 11.2
109 glucocorticoid deficiency 4 with or without mineralocorticoid deficiency 11.2
110 congenital disorder of glycosylation, type it 11.2
111 glucocorticoid resistance, generalized 11.2
112 tenorio syndrome 11.2
113 shashi-pena syndrome 11.2
114 3-methylglutaconic aciduria, type i 11.2
115 3-methylglutaconic aciduria, type iv 11.2
116 diencephalic syndrome 11.2
117 diazoxide-resistant diffuse hyperinsulinism 11.1
118 diazoxide-sensitive diffuse hyperinsulinism 11.1
119 hyperinsulinism due to hnf4a deficiency 11.1
120 diazoxide-resistant hyperinsulinism 11.1
121 hyperinsulinism due to ucp2 deficiency 11.1
122 hyperinsulinism due to hnf1a deficiency 11.1
123 diazoxide-resistant focal hyperinsulinism 11.1
124 mitochondrial complex iii deficiency, nuclear type 1 11.1
125 glycogen storage disease ib 11.1
126 glycogen storage disease ic 11.1
127 laron syndrome 11.1
128 adrenal hypoplasia, congenital 11.1
129 barth syndrome 11.1
130 3-hydroxy-3-methylglutaryl-coa synthase-2 deficiency 11.1
131 obesity, early-onset, with adrenal insufficiency and red hair 11.1
132 combined malonic and methylmalonic aciduria 11.1
133 microcephaly, short stature, and impaired glucose metabolism 1 11.1
134 mitochondrial dna depletion syndrome 15 11.1
135 glucocorticoid deficiency 5 11.1
136 orthostatic hypotension 2 11.1
137 dopamine beta-hydroxylase deficiency 11.1
138 carbonic anhydrase va deficiency 11.1
139 medium-chain acyl-coenzyme a dehydrogenase deficiency 11.1
140 3-alpha hydroxyacyl-coa dehydrogenase deficiency 11.1
141 classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency 11.1
142 insulin-resistance type b 11.1
143 silver-russell syndrome 1 10.9
144 alpha-ketoglutarate dehydrogenase deficiency 10.9
145 orthostatic hypotension 1 10.9
146 hemochromatosis, neonatal 10.9
147 dihydrolipoamide dehydrogenase deficiency 10.9
148 mitochondrial dna depletion syndrome 6 10.9
149 5-oxoprolinase deficiency 10.9
150 phosphoenolpyruvate carboxykinase deficiency, mitochondrial 10.9
151 glycogen storage disease of heart, lethal congenital 10.9
152 proprotein convertase 1/3 deficiency 10.9
153 glycogen storage disease 0, muscle 10.9
154 obesity, hyperphagia, and developmental delay 10.9
155 pituitary hormone deficiency, combined, 6 10.9
156 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 10.9
157 3-methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome 10.9
158 growth hormone deficiency, isolated partial 10.9
159 mitochondrial complex iii deficiency, nuclear type 9 10.9
160 polyendocrine-polyneuropathy syndrome 10.9
161 metabolic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration 10.9
162 sedoheptulokinase deficiency 10.9
163 mitochondrial complex v deficiency, nuclear type 5 10.9
164 tango2-related metabolic encephalopathy and arrhythmias 10.9
165 2-methyl-3-hydroxybutyric aciduria 10.9
166 paroxysmal exertion-induced dyskinesia 10.9
167 autoimmune addison disease 10.9
168 ocular motor apraxia 10.8
169 islet cell tumor 10.7
170 maturity-onset diabetes of the young, type 8, with exocrine dysfunction 10.7 KCNJ11 GCK ABCC8
171 maturity-onset diabetes of the young, type 13 10.7 KCNJ11 GCK ABCC8
172 maturity-onset diabetes of the young, type 7 10.6 KCNJ11 GCK ABCC8
173 maturity-onset diabetes of the young, type 10 10.6 KCNJ11 INS ABCC8
174 maturity-onset diabetes of the young, type 9 10.6 KCNJ11 GCK ABCC8
175 maturity-onset diabetes of the young, type 6 10.6 KCNJ11 GCK ABCC8
176 fanconi-bickel syndrome 10.6 INS G6PC ABCC8
177 maturity-onset diabetes of the young, type 4 10.6 KCNJ11 INS GCK ABCC8
178 renal cysts and diabetes syndrome 10.6 KCNJ11 GCK ABCC8
179 pancreatic agenesis 10.6 KCNJ11 INS GCK ABCC8
180 pancreatic cystadenoma 10.6 INS GCK GCG ABCC8
181 rare diabetes mellitus type 2 10.6 KCNJ11 INSR GCK AKT2 ABCC8
182 fetal erythroblastosis 10.6 HADH GLUD1
183 maturity-onset diabetes of the young, type 11 10.6 KCNJ11 ABCC8
184 wolfram syndrome 1 10.6 KCNJ11 INS CRH
185 pituitary infarct 10.5 INS CRH
186 autonomic neuropathy 10.5
187 glycogen storage disease iv 10.5 GYS2 G6PC CPT2
188 myoglobinuria, recurrent 10.5 CPT2 ACADVL
189 lactic acidosis 10.5
190 postgastrectomy syndrome 10.5 INS GCG
191 adenoma 10.5
192 seizure disorder 10.5
193 visual epilepsy 10.4
194 kidney disease 10.4
195 hypoxia 10.4
196 dumping syndrome 10.4
197 hypopituitarism 10.4
198 growth hormone deficiency 10.4
199 neuropathy 10.4
200 end stage renal disease 10.4
201 lipid storage disease 10.4 INS GCG CPT1A
202 hemangiopericytoma, malignant 10.4
203 potter's syndrome 10.4
204 encephalopathy 10.4
205 metabolic acidosis 10.3
206 fibrosarcoma 10.3
207 congestive heart failure 10.3
208 pheochromocytoma 10.3
209 adrenal gland pheochromocytoma 10.3
210 hypothyroidism 10.3
211 hypokalemia 10.3
212 anorexia nervosa 10.3
213 diabetic autonomic neuropathy 10.3
214 hepatocellular carcinoma 10.3
215 benign mesothelioma 10.3
216 chronic kidney disease 10.3
217 anoxia 10.3
218 neuroendocrine tumor 10.2
219 ischemia 10.2
220 tremor 10.2
221 diarrhea 10.2
222 duodenal ulcer 10.2
223 pancreatitis 10.2
224 autonomic dysfunction 10.2
225 syncope 10.2
226 alcohol dependence 10.2
227 peripheral nervous system disease 10.2
228 leptin deficiency or dysfunction 10.2
229 respiratory failure 10.2
230 bilirubin metabolic disorder 10.2
231 brain injury 10.2
232 gastrointestinal stromal tumor 10.2
233 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.2
234 leukemia 10.2
235 liver cirrhosis 10.2
236 leiomyosarcoma 10.2
237 mesenchymal cell neoplasm 10.2
238 fatty liver disease 10.2
239 leukemia, acute lymphoblastic 10.2
240 pulmonary edema 10.2
241 dementia 10.2
242 cholestasis 10.2
243 multiple endocrine neoplasia 10.2
244 liver disease 10.2
245 hyperthyroidism 10.2
246 48,xyyy 10.2
247 dwarfism 10.2
248 pure autonomic failure 10.2
249 yemenite deaf-blind hypopigmentation syndrome 10.1
250 acute pancreatitis 10.1
251 lipid metabolism disorder 10.1
252 inherited metabolic disorder 10.1
253 peptic ulcer disease 10.1
254 hypotonia 10.1
255 overgrowth syndrome 10.1
256 cardiac arrhythmia 10.1
257 body mass index quantitative trait locus 1 10.1
258 cardiac arrest 10.1
259 hemiplegia 10.1
260 graves' disease 10.1
261 acromegaly 10.1
262 acute kidney failure 10.1
263 cerebrovascular disease 10.1
264 pituitary tumors 10.1
265 multiple endocrine neoplasia, type i 10.1
266 macroglossia 10.1
267 cystic fibrosis 10.1
268 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
269 microvascular complications of diabetes 5 10.1
270 isolated growth hormone deficiency 10.1
271 allergic hypersensitivity disease 10.1
272 toxic shock syndrome 10.1
273 reye syndrome 10.1
274 polycythemia 10.1
275 47,xyy 10.1
276 hypercholesterolemia, familial, 1 10.1
277 systemic lupus erythematosus 10.1
278 myocardial infarction 10.1
279 adrenal cortical carcinoma 10.1
280 autosomal recessive disease 10.1
281 microcephaly 10.1
282 heart disease 10.1
283 status epilepticus 10.1
284 gastroenteritis 10.1
285 congenital hypopituitarism 10.1
286 autoimmune disease 10.0
287 adrenocortical carcinoma, hereditary 10.0
288 body mass index quantitative trait locus 9 10.0
289 body mass index quantitative trait locus 8 10.0
290 body mass index quantitative trait locus 4 10.0
291 body mass index quantitative trait locus 10 10.0
292 body mass index quantitative trait locus 7 10.0
293 body mass index quantitative trait locus 12 10.0
294 body mass index quantitative trait locus 14 10.0
295 body mass index quantitative trait locus 18 10.0
296 body mass index quantitative trait locus 19 10.0
297 body mass index quantitative trait locus 20 10.0
298 fibroma 10.0
299 acute cystitis 10.0
300 alcohol use disorder 10.0
301 vascular disease 10.0
302 epilepsy 10.0
303 cerebral palsy 10.0
304 adrenal cortical adenocarcinoma 10.0
305 uremia 10.0
306 paraneoplastic syndromes 10.0
307 cyanosis, transient neonatal 10.0
308 hyperprolactinemia 10.0
309 sarcoma 10.0
310 hypogonadism 10.0
311 spindle cell sarcoma 10.0
312 cataract 10.0
313 acute myocardial infarction 10.0
314 diabetes insipidus 10.0
315 depression 10.0
316 rare tumor 10.0
317 primary adrenal insufficiency 10.0
318 hypertension, essential 10.0
319 hypertriglyceridemia, familial 10.0
320 immune deficiency disease 10.0
321 pituitary hormone deficiency, combined, 2 10.0
322 ataxia and polyneuropathy, adult-onset 10.0
323 anxiety 10.0
324 hypophosphatemia 10.0
325 second-degree atrioventricular block 10.0
326 lymphoma 10.0
327 hyperparathyroidism 10.0
328 thrombocytopenia 10.0
329 factitious disorder 10.0
330 pituitary adenoma 10.0
331 hypertrichosis 10.0
332 pustulosis of palm and sole 10.0
333 neuroblastoma 10.0
334 lupus erythematosus 10.0
335 psoriasis 10.0
336 amyloidosis 10.0
337 muscular dystrophy 10.0
338 fainting 10.0
339 glycogen storage disease due to glucose-6-phosphatase deficiency 10.0
340 acyl-coa dehydrogenase deficiency 10.0
341 fibrosis of extraocular muscles, congenital, 1 9.9
342 kabuki syndrome 1 9.9
343 celiac disease 1 9.9
344 myeloma, multiple 9.9
345 myxedema 9.9
346 graves disease 1 9.9
347 malaria 9.9
348 atrial fibrillation 9.9
349 pre-eclampsia 9.9
350 cortical blindness 9.9
351 neutropenia 9.9
352 amenorrhea 9.9
353 benign breast phyllodes tumor 9.9
354 neuroendocrine carcinoma 9.9
355 hyperuricemia 9.9
356 hepatitis 9.9
357 hemangioma 9.9
358 adenocarcinoma 9.9
359 hemolytic anemia 9.9
360 acquired immunodeficiency syndrome 9.9
361 diabetic neuropathy 9.9
362 mitochondrial disorders 9.9
363 secondary adrenal insufficiency 9.9
364 headache 9.9
365 adenoma of pancreas 9.9
366 atherosclerosis susceptibility 9.9
367 sotos syndrome 1 9.9
368 renal cell carcinoma, nonpapillary 9.9
369 scleroderma, familial progressive 9.9
370 costello syndrome 9.9
371 aging 9.9
372 coronary heart disease 1 9.9
373 major depressive disorder 9.9
374 microvascular complications of diabetes 3 9.9
375 microvascular complications of diabetes 4 9.9
376 microvascular complications of diabetes 6 9.9
377 microvascular complications of diabetes 7 9.9
378 fatty liver disease, nonalcoholic 1 9.9
379 angina pectoris 9.9
380 west syndrome 9.9
381 fetal alcohol syndrome 9.9
382 alcohol-related birth defect 9.9
383 zollinger-ellison syndrome 9.9
384 sleep apnea 9.9
385 disseminated intravascular coagulation 9.9
386 polycystic ovary syndrome 9.9
387 chagas disease 9.9
388 generalized anxiety disorder 9.9
389 personality disorder 9.9
390 urticaria 9.9
391 mental depression 9.9
392 long qt syndrome 9.9
393 breast malignant phyllodes tumor 9.9
394 carcinosarcoma 9.9
395 brain edema 9.9
396 b-cell lymphoma 9.9
397 thyroiditis 9.9
398 intermediate coronary syndrome 9.9
399 myotonic dystrophy 9.9
400 congenital disorders of n-linked glycosylation and multiple pathway 9.9
401 broken heart syndrome 9.9
402 central congenital hypothyroidism 9.9
403 cerebral atrophy 9.9
404 cerebral hypoxia 9.9
405 head injury 9.9
406 traumatic brain injury 9.9
407 posttransplant acute limbic encephalitis 9.9
408 adrenogenital syndrome 9.9
409 cardiogenic shock 9.9
410 peripheral vascular disease 9.9
411 protein-energy malnutrition 9.9
412 acanthosis nigricans 9.8
413 arteries, anomalies of 9.8
414 cardiac conduction defect 9.8
415 prader-willi syndrome 9.8
416 proteus syndrome 9.8
417 dowling-degos disease 1 9.8
418 rheumatoid arthritis 9.8
419 sarcoidosis 1 9.8
420 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.8
421 enterocolitis 9.8
422 hemihyperplasia, isolated 9.8
423 lymphoma, hodgkin, classic 9.8
424 polycythemia vera 9.8
425 asthma 9.8
426 stroke, ischemic 9.8
427 ventricular fibrillation, paroxysmal familial, 1 9.8
428 lymphoma, non-hodgkin, familial 9.8
429 patent ductus arteriosus 1 9.8
430 gastric cancer 9.8
431 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.8
432 chorea, childhood-onset, with psychomotor retardation 9.8
433 hyperlipoproteinemia, type iii 9.8
434 lipoprotein quantitative trait locus 9.8
435 pulmonary hypertension 9.8
436 small cell carcinoma 9.8
437 atrioventricular block 9.8
438 aphasia 9.8
439 organic acidemia 9.8
440 omphalocele 9.8
441 childhood acute lymphocytic leukemia 9.8
442 non-alcoholic fatty liver disease 9.8
443 hypogonadotropic hypogonadism 9.8
444 endocarditis 9.8
445 hepatorenal syndrome 9.8
446 pancytopenia 9.8
447 pyloric stenosis 9.8
448 locked-in syndrome 9.8
449 leiomyoma 9.8
450 quadriplegia 9.8
451 thyroid crisis 9.8
452 choreatic disease 9.8
453 hellp syndrome 9.8
454 kwashiorkor 9.8
455 methylmalonic acidemia 9.8
456 peritoneal mesothelioma 9.8
457 hepatitis c 9.8
458 constipation 9.8
459 transient cerebral ischemia 9.8
460 agammaglobulinemia 9.8
461 rhabdomyosarcoma 9.8
462 central nervous system disease 9.8
463 purpura 9.8
464 neurofibrosarcoma 9.8
465 empty sella syndrome 9.8
466 craniopharyngioma 9.8
467 placental insufficiency 9.8
468 adrenal carcinoma 9.8
469 somatostatinoma 9.8
470 neurotic disorder 9.8
471 gastric leiomyosarcoma 9.8
472 sleep disorder 9.8
473 retroperitoneal hemangiopericytoma 9.8
474 pneumonia 9.8
475 malignant peripheral nerve sheath tumor 9.8
476 paraplegia 9.8
477 central pontine myelinolysis 9.8
478 hepatoblastoma 9.8
479 mitochondrial metabolism disease 9.8
480 pituitary hypoplasia 9.8
481 intestinal obstruction 9.8
482 lung disease 9.8
483 nervous system disease 9.8
484 eating disorder 9.8
485 perinatal necrotizing enterocolitis 9.8
486 hypereosinophilic syndrome 9.8
487 chromosomal triplication 9.8
488 glucagonoma 9.8
489 lymphosarcoma 9.8
490 pancreatic adenoma 9.8
491 persistent vegetative state 9.8
492 neonatal hypoxic and ischemic brain injury 9.8
493 rapidly involuting congenital hemangioma 9.8
494 specific language disorder 9.8
495 acute liver failure 9.8
496 paternal uniparental disomy 9.8
497 thyroid carcinoma 9.8
498 fanconi renotubular syndrome 1 9.8
499 polycystic liver disease 1 with or without kidney cysts 9.8
500 severe pre-eclampsia 9.8
501 ventricular septal defect 9.8
502 heart septal defect 9.8
503 systemic scleroderma 9.8
504 retroperitoneal leiomyosarcoma 9.8
505 severe combined immunodeficiency 9.8
506 encephalitis 9.8
507 alzheimer disease 9.7
508 spondyloarthropathy 1 9.7
509 burkitt lymphoma 9.7
510 breast cancer 9.7
511 migraine with or without aura 1 9.7
512 ovarian cancer 9.7
513 parkinson disease, late-onset 9.7
514 ruvalcaba syndrome 9.7
515 buerger disease 9.7
516 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.7
517 hemochromatosis, type 1 9.7
518 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.7
519 hypoadrenocorticism, familial 9.7
520 macrocephaly/megalencephaly syndrome, autosomal recessive 9.7
521 shwachman-diamond syndrome 1 9.7
522 helicobacter pylori infection 9.7
523 pituitary adenoma, prolactin-secreting 9.7
524 preaxial hallucal polydactyly 9.7
525 branchiootic syndrome 1 9.7
526 meningioma, radiation-induced 9.7
527 polysubstance abuse 9.7
528 meningioma, familial 9.7
529 bulimia nervosa 9.7
530 psoriatic arthritis 9.7
531 major affective disorder 8 9.7
532 major affective disorder 9 9.7
533 muscular dystrophy, congenital, lmna-related 9.7
534 alpha-1-antitrypsin deficiency 9.7
535 long qt syndrome 2 9.7
536 aspergillosis 9.7
537 alacrima, achalasia, and mental retardation syndrome 9.7
538 polymicrogyria with or without vascular-type ehlers-danlos syndrome 9.7
539 deficiency anemia 9.7
540 angiosarcoma 9.7
541 hyperphosphatemia 9.7
542 exanthem 9.7
543 diffuse large b-cell lymphoma 9.7
544 paraganglioma 9.7
545 tonsil squamous cell carcinoma 9.7
546 infective endocarditis 9.7
547 pain agnosia 9.7
548 colitis 9.7
549 basal ganglia calcification 9.7
550 3-methylglutaconic aciduria 9.7
551 thrombosis 9.7
552 mucositis 9.7
553 type 1 diabetes mellitus 10 9.7
554 sensorineural hearing loss 9.7
555 trypanosomiasis 9.7
556 gastric ulcer 9.7
557 plethora of newborn 9.7
558 pneumocystosis 9.7
559 spinal meningioma 9.7
560 nephrotic syndrome 9.7
561 gastroparesis 9.7
562 conn's syndrome 9.7
563 inflammatory spondylopathy 9.7
564 common variable immunodeficiency 9.7
565 retroperitoneal sarcoma 9.7
566 bronchopneumonia 9.7
567 secondary hyperparathyroidism 9.7
568 gout 9.7
569 gonadal dysgenesis 9.7
570 avoidant personality disorder 9.7
571 endogenous depression 9.7
572 squamous cell carcinoma 9.7
573 malignant fibrous histiocytoma 9.7
574 rectum cancer 9.7
575 encephalomalacia 9.7
576 enthesopathy 9.7
577 focal epilepsy 9.7
578 arteriosclerosis 9.7
579 iron metabolism disease 9.7
580 teratoma 9.7
581 bipolar disorder 9.7
582 mood disorder 9.7
583 cellulitis 9.7
584 gastric adenocarcinoma 9.7
585 syphilis 9.7
586 pseudohypoparathyroidism 9.7
587 fibrous histiocytoma 9.7
588 pancreatic somatostatinoma 9.7
589 large cell carcinoma 9.7
590 subacute bacterial endocarditis 9.7
591 secretory meningioma 9.7
592 lymphoplasmacyte-rich meningioma 9.7
593 movement disease 9.7
594 infertility 9.7
595 retinal disease 9.7
596 malignant mesenchymoma 9.7
597 panic disorder 9.7
598 bronchitis 9.7
599 cowden syndrome 9.7
600 spondylitis 9.7
601 muscular atrophy 9.7
602 arthritis 9.7
603 ulcerative colitis 9.7
604 subacute delirium 9.7
605 chickenpox 9.7
606 narcolepsy 9.7
607 congenital syphilis 9.7
608 polymicrogyria 9.7
609 sickle cell disease 9.7
610 carcinoid syndrome 9.7
611 desmoplastic small round cell tumor 9.7
612 lymphocytic hypophysitis 9.7
613 dysphagia 9.7
614 febrile seizures 9.7
615 megalencephaly 9.7
616 paresthesia 9.7
617 malignant peritoneal mesothelioma 9.7
618 paroxysmal dyskinesia 9.7
619 premature aging 9.7
620 neurofibromatosis, type ii 9.7
621 pfeiffer syndrome 9.7
622 behcet syndrome 9.7
623 progressive familial heart block, type ia 9.7
624 lymphoma, mucosa-associated lymphoid type 9.7
625 hypertelorism 9.7
626 thyroid carcinoma, familial medullary 9.7
627 medulloblastoma 9.7
628 visceral myopathy 9.7
629 prostate cancer 9.7
630 schizophrenia 9.7
631 chromosome 2q35 duplication syndrome 9.7
632 wolf-hirschhorn syndrome 9.7
633 ascites, chylous 9.7
634 central hypoventilation syndrome, congenital 9.7
635 3-methylcrotonyl-coa carboxylase 1 deficiency 9.7
636 jervell and lange-nielsen syndrome 1 9.7
637 glutaric acidemia i 9.7
638 3-hydroxyisobutyric aciduria 9.7
639 succinyl-coa:3-oxoacid-coa transferase deficiency 9.7
640 familial mediterranean fever 9.7
641 3-methylglutaconic aciduria, type iii 9.7
642 orotic aciduria 9.7
643 osteogenic sarcoma 9.7
644 sarcoma, synovial 9.7
645 arts syndrome 9.7
646 androgen insensitivity, partial 9.7
647 dermatitis, atopic 9.7
648 citrullinemia, type ii, adult-onset 9.7
649 leukoencephalopathy with vanishing white matter 9.7
650 nasopharyngeal carcinoma 9.7
651 choanal atresia, posterior 9.7
652 valproate embryopathy 9.7
653 isobutyryl-coa dehydrogenase deficiency 9.7
654 mitochondrial complex iii deficiency, nuclear type 3 9.7
655 infantile liver failure syndrome 1 9.7
656 anaplastic large cell lymphoma 9.7
657 diabetic encephalopathy 9.7
658 cerebellar medulloblastoma 9.7
659 brain meningioma 9.7
660 chromosome 16p11.2 deletion syndrome 9.7
661 intrahepatic cholestasis of pregnancy 9.7
662 myxofibrosarcoma 9.7
663 covid-19 9.7
664 left bundle branch hemiblock 9.7
665 osteomalacia 9.7
666 microphthalmia 9.7
667 japanese encephalitis 9.7
668 spastic diplegia 9.7
669 placenta praevia 9.7
670 brucellosis 9.7
671 prostatic hypertrophy 9.7
672 coronary thrombosis 9.7
673 synostosis 9.7
674 oligohydramnios 9.7
675 acute kidney tubular necrosis 9.7
676 dilated cardiomyopathy 9.7
677 uveitis 9.7
678 mitral valve stenosis 9.7
679 neonatal jaundice 9.7
680 leydig cell tumor 9.7
681 tic disorder 9.7
682 severe acute respiratory syndrome 9.7
683 churg-strauss syndrome 9.7
684 inappropriate adh syndrome 9.7
685 plasmacytoma 9.7
686 anovulation 9.7
687 thyroid gland medullary carcinoma 9.7
688 duodenogastric reflux 9.7
689 clear cell sarcoma 9.7
690 clear cell renal cell carcinoma 9.7
691 rhinitis 9.7
692 benign ependymoma 9.7
693 alcoholic pancreatitis 9.7
694 benign pleural mesothelioma 9.7
695 anterograde amnesia 9.7
696 cellular ependymoma 9.7
697 epithelioid sarcoma 9.7
698 malignant pleural mesothelioma 9.7
699 myocarditis 9.7
700 decubitus ulcer 9.7
701 toxic myocarditis 9.7
702 radioulnar synostosis 9.7
703 miliary tuberculosis 9.7
704 bap1 tumor predisposition syndrome 9.7
705 childhood ataxia with central nervous system hypomyelination / vanishing white matter 9.7
706 allergic angiitis 9.7
707 chromosome 4p deletion 9.7
708 hemorrhagic shock and encephalopathy syndrome 9.7
709 microscopic polyangiitis 9.7
710 mosaic trisomy 13 9.7
711 plasmablastic lymphoma 9.7
712 precocious puberty 9.7
713 spinal shock 9.7
714 raynaud phenomenon 9.7
715 familial long qt syndrome 9.7
716 ring chromosome 9.7
717 amelia 9.7
718 prenatal-onset spinal muscular atrophy with congenital bone fractures 9.7
719 hyperpigmentation of the skin 9.7
720 apert syndrome 9.6
721 colorectal cancer 9.6
722 seizures, benign familial neonatal, 1 9.6
723 esophageal cancer 9.6
724 coffin-siris syndrome 1 9.6
725 hair whorl 9.6
726 hashimoto thyroiditis 9.6
727 attention deficit-hyperactivity disorder 9.6
728 hyperostosis frontalis interna 9.6
729 multiple system atrophy 1 9.6
730 meniere disease 9.6
731 mesothelioma, malignant 9.6
732 cowden syndrome 1 9.6
733 facioscapulohumeral muscular dystrophy 1 9.6
734 episodic ataxia, type 1 9.6
735 neurofibromatosis, type i 9.6
736 noonan syndrome 1 9.6
737 optic nerve hypoplasia, bilateral 9.6
738 teratoma, ovarian 9.6
739 pancreatitis, hereditary 9.6
740 retinoblastoma 9.6
741 strabismus 9.6
742 thrombophilia due to thrombin defect 9.6
743 thyroid cancer, nonmedullary, 1 9.6
744 tuberous sclerosis 1 9.6
745 alpha-methylacetoacetic aciduria 9.6
746 anemia, autoimmune hemolytic 9.6
747 autism 9.6
748 congenital disorder of glycosylation, type ia 9.6
749 peroxisome biogenesis disorder 1a 9.6
750 charge syndrome 9.6
751 pituitary adenoma 4, acth-secreting 9.6
752 dandy-walker syndrome 9.6
753 visceral steatosis, congenital 9.6
754 galactorrhea 9.6
755 hydrocephalus, congenital, 1 9.6
756 isovaleric acidemia 9.6
757 johanson-blizzard syndrome 9.6
758 leprosy 3 9.6
759 methylmalonic aciduria, cblb type 9.6
760 biotinidase deficiency 9.6
761 holocarboxylase synthetase deficiency 9.6
762 myopathy, congenital 9.6
763 pancreatic cancer 9.6
764 pancreatic agenesis 1 9.6
765 phenylketonuria 9.6
766 epilepsy, pyridoxine-dependent 9.6
767 pyruvate carboxylase deficiency 9.6
768 respiratory distress syndrome in premature infants 9.6
769 reticulum cell sarcoma 9.6
770 retinitis pigmentosa 9.6
771 succinic semialdehyde dehydrogenase deficiency 9.6
772 sudden infant death syndrome 9.6
773 thymoma, familial 9.6
774 hypothyroidism, congenital, nongoitrous, 4 9.6
775 adrenoleukodystrophy 9.6
776 mehmo syndrome 9.6
777 coats disease 9.6
778 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.6
779 glycerol kinase deficiency 9.6
780 muscular dystrophy, duchenne type 9.6
781 otopalatodigital syndrome, type i 9.6
782 oncocytoma 9.6
783 gallbladder disease 1 9.6
784 congenital disorder of glycosylation, type id 9.6
785 diabetes mellitus, insulin-dependent, 11 9.6
786 macular degeneration, age-related, 1 9.6
787 pseudohypoparathyroidism, type ib 9.6
788 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 9.6
789 polydactyly 9.6
790 cervical cancer 9.6
791 langerhans cell histiocytosis 9.6
792 homozygous 11p15-p14 deletion syndrome 9.6
793 bone mineral density quantitative trait locus 3 9.6
794 creatinine clearance quantitative trait locus 9.6
795 resting heart rate, variation in 9.6
796 mycobacterium tuberculosis 1 9.6
797 endometrial cancer 9.6
798 kala-azar 1 9.6
799 leukemia, chronic myeloid 9.6
800 phobia, specific 9.6
801 platelet glycoprotein iv deficiency 9.6
802 human immunodeficiency virus type 1 9.6
803 hepatitis c virus 9.6
804 chromosome 16p13.3 deletion syndrome, proximal 9.6
805 lung cancer susceptibility 3 9.6
806 fanconi renotubular syndrome 2 9.6
807 mitochondrial complex v deficiency, nuclear type 3 9.6
808 psoriasis 14, pustular 9.6
809 leukemia, acute lymphoblastic 3 9.6
810 cholangiocarcinoma 9.6
811 analbuminemia 9.6
812 2,4-dienoyl-coa reductase deficiency 9.6
813 hyperproinsulinemia 9.6
814 corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia 9.6
815 striatal degeneration, autosomal dominant 2 9.6
816 combined oxidative phosphorylation deficiency 34 9.6
817 bacterial sepsis 9.6
818 drug-induced lupus erythematosus 9.6
819 invasive aspergillosis 9.6
820 acute diarrhea 9.6
821 congenital hypothyroidism 9.6
822 restless legs syndrome 9.6
823 chorioamnionitis 9.6
824 biotin deficiency 9.6
825 hemorrhagic cystitis 9.6
826 colorectal adenocarcinoma 9.6
827 follicular lymphoma 9.6
828 gastrointestinal carcinoma 9.6
829 extra-adrenal pheochromocytoma 9.6
830 withdrawal disorder 9.6
831 pervasive developmental disorder 9.6
832 autism spectrum disorder 9.6
833 agraphia 9.6
834 ptosis 9.6
835 angular cheilitis 9.6
836 lung abscess 9.6
837 umbilical hernia 9.6
838 myelomeningocele 9.6
839 hereditary lymphedema i 9.6
840 mitochondrial dna depletion syndrome 9.6
841 bone resorption disease 9.6
842 polycystic kidney disease 9.6
843 malignant pheochromocytoma 9.6
844 dedifferentiated liposarcoma 9.6
845 non-alcoholic steatohepatitis 9.6
846 urolithiasis 9.6
847 type 1 diabetes mellitus 12 9.6
848 asymptomatic neurosyphilis 9.6
849 gastric leiomyoma 9.6
850 sleeping sickness 9.6
851 cerebral artery occlusion 9.6
852 neuroretinitis 9.6
853 cholelithiasis 9.6
854 dermatomyositis 9.6
855 thalassemia 9.6
856 mumps 9.6
857 suppression amblyopia 9.6
858 amblyopia 9.6
859 disuse amblyopia 9.6
860 bacterial infectious disease 9.6
861 tonsillitis 9.6
862 nasopharyngitis 9.6
863 esophageal atresia 9.6
864 cardia cancer 9.6
865 short bowel syndrome 9.6
866 rickets 9.6
867 protein-losing enteropathy 9.6
868 fanconi syndrome 9.6
869 cystinosis 9.6
870 renal hypertension 9.6
871 thrombotic thrombocytopenic purpura 9.6
872 methemoglobinemia 9.6
873 premature menopause 9.6
874 lepromatous leprosy 9.6
875 hydrocephalus 9.6
876 amnestic disorder 9.6
877 multiple personality disorder 9.6
878 bartonellosis 9.6
879 pertussis 9.6
880 hypoparathyroidism 9.6
881 primary hyperparathyroidism 9.6
882 social phobia 9.6
883 pituitary apoplexy 9.6
884 hemopericardium 9.6
885 hyperandrogenism 9.6
886 patau syndrome 9.6
887 iron deficiency anemia 9.6
888 pericardial effusion 9.6
889 esophagitis 9.6
890 hypertrophic cardiomyopathy 9.6
891 hemosiderosis 9.6
892 primary biliary cirrhosis 9.6
893 alcoholic hepatitis 9.6
894 spinal muscular atrophy 9.6
895 complex partial epilepsy 9.6
896 von willebrand's disease 9.6
897 hepatic coma 9.6
898 neonatal thyrotoxicosis 9.6
899 acute leukemia 9.6
900 hypertrophic pyloric stenosis 9.6
901 newborn respiratory distress syndrome 9.6
902 carotid stenosis 9.6
903 relapsing fever 9.6
904 background diabetic retinopathy 9.6
905 porphyria 9.6
906 exocrine pancreatic insufficiency 9.6
907 hepatic encephalopathy 9.6
908 urethritis 9.6
909 tuberous sclerosis 9.6
910 eclampsia 9.6
911 nutmeg liver 9.6
912 sick sinus syndrome 9.6
913 polyneuropathy 9.6
914 peptic esophagitis 9.6
915 plasmodium falciparum malaria 9.6
916 46 xx gonadal dysgenesis 9.6
917 lymphadenitis 9.6
918 pneumothorax 9.6
919 cystitis 9.6
920 ichthyosis 9.6
921 cheilitis 9.6
922 pancreatic endocrine carcinoma 9.6
923 ossifying fibroma 9.6
924 viral hepatitis 9.6
925 hepatitis b 9.6
926 autoimmune hepatitis 9.6
927 hyperostosis 9.6
928 thrombocytosis 9.6
929 pharyngitis 9.6
930 craniosynostosis 9.6
931 hyperpituitarism 9.6
932 psychotic disorder 9.6
933 opiate dependence 9.6
934 pancreas disease 9.6
935 kidney cancer 9.6
936 liver sarcoma 9.6
937 dermatitis 9.6
938 capillary hemangioma 9.6
939 hairy cell leukemia 9.6
940 euthyroid sick syndrome 9.6
941 hemoglobinopathy 9.6
942 glucosephosphate dehydrogenase deficiency 9.6
943 newcastle disease 9.6
944 pulmonary tuberculosis 9.6
945 primary hyperoxaluria 9.6
946 anuria 9.6
947 acinar cell carcinoma 9.6
948 astrocytoma 9.6
949 malignant glioma 9.6
950 interstitial lung disease 9.6
951 cystadenocarcinoma 9.6
952 papillary carcinoma 9.6
953 serous cystadenocarcinoma 9.6
954 embryonal rhabdomyosarcoma 9.6
955 thymoma 9.6
956 angiomyolipoma 9.6
957 fibrosarcoma of bone 9.6
958 liposarcoma 9.6
959 histiocytosis 9.6
960 turner syndrome 9.6
961 middle cerebral artery infarction 9.6
962 ovarian cystadenocarcinoma 9.6
963 retinitis 9.6
964 skin disease 9.6
965 esophagus squamous cell carcinoma 9.6
966 pulmonary fibrosis 9.6
967 spindle cell carcinoma 9.6
968 gastritis 9.6
969 heart valve disease 9.6
970 rh isoimmunization 9.6
971 neuromuscular disease 9.6
972 dysgraphia 9.6
973 familial retinoblastoma 9.6
974 intracranial hypotension 9.6
975 pulmonary blastoma 9.6
976 embryoma 9.6
977 classic pulmonary blastoma 9.6
978 intrahepatic cholangiocarcinoma 9.6
979 tubular adenocarcinoma 9.6
980 poliomyelitis 9.6
981 thyroid gland disease 9.6
982 fibrolamellar carcinoma 9.6
983 hepatocellular clear cell carcinoma 9.6
984 aortitis 9.6
985 urinary tract obstruction 9.6
986 epithelioid leiomyosarcoma 9.6
987 schizoaffective disorder 9.6
988 dystonia 9.6
989 scrapie 9.6
990 ovarian germ cell teratoma 9.6
991 gastrinoma 9.6
992 pancreatic acinar cell adenocarcinoma 9.6
993 agoraphobia 9.6
994 uterine carcinosarcoma 9.6
995 conjunctivitis 9.6
996 gastric cardia adenocarcinoma 9.6
997 fibromyalgia 9.6
998 connective tissue disease 9.6
999 plasma cell neoplasm 9.6
1000 adrenal adenoma 9.6
1001 cervix small cell carcinoma 9.6
1002 juvenile pilocytic astrocytoma 9.6
1003 acth-secreting pituitary adenoma 9.6
1004 axonal neuropathy 9.6
1005 active peptic ulcer disease 9.6
1006 peptic ulcer perforation 9.6
1007 parathyroid adenoma 9.6
1008 placenta disease 9.6
1009 liver fibrosarcoma 9.6
1010 septic arthritis 9.6
1011 peritonitis 9.6
1012 osteoarthritis 9.6
1013 ileus 9.6
1014 mucormycosis 9.6
1015 polyhydramnios 9.6
1016 monocytic leukemia 9.6
1017 reticulosarcoma 9.6
1018 sezary's disease 9.6
1019 chronic fatigue syndrome 9.6
1020 malignant hyperthermia 9.6
1021 multiple carboxylase deficiency 9.6
1022 measles 9.6
1023 vasculitis 9.6
1024 myeloid leukemia 9.6
1025 vascular dementia 9.6
1026 crohn's disease 9.6
1027 learning disability 9.6
1028 hepatopulmonary syndrome 9.6
1029 leishmaniasis 9.6
1030 macroglobulinemia 9.6
1031 achalasia 9.6
1032 tyrosinemia 9.6
1033 cleft lip 9.6
1034 mechanical strabismus 9.6
1035 scotoma 9.6
1036 exophthalmos 9.6
1037 intracranial hypertension 9.6
1038 meningitis 9.6
1039 fasciitis 9.6
1040 necrotizing fasciitis 9.6
1041 babesiosis 9.6
1042 pathologic nystagmus 9.6
1043 trichinosis 9.6
1044 insr-related severe syndromic insulin resistance 9.6
1045 isolated methylmalonic acidemia 9.6
1046 lama2-related muscular dystrophy 9.6
1047 absence of septum pellucidum 9.6
1048 acute ackee fruit intoxication 9.6
1049 acute mountain sickness 9.6
1050 adrenomyeloneuropathy 9.6
1051 al amyloidosis 9.6
1052 aminoaciduria 9.6
1053 anca-associated vasculitis 9.6
1054 bronchial adenomas/carcinoids childhood 9.6
1055 chiari malformation 9.6
1056 cytokine deficiency 9.6
1057 fibromatosis 9.6
1058 germ cells tumors 9.6
1059 gigantism 9.6
1060 glioma 9.6
1061 hansen's disease 9.6
1062 hereditary amyloidosis 9.6
1063 hypnic headache 9.6
1064 meningococcemia 9.6
1065 neurosyphilis 9.6
1066 non-involuting congenital hemangioma 9.6
1067 primary orthostatic hypotension 9.6
1068 proteus-like syndrome 9.6
1069 pseudo-turner syndrome 9.6
1070 pustular psoriasis 9.6
1071 retroperitoneal liposarcoma 9.6
1072 soft tissue sarcoma 9.6
1073 splenomegaly 9.6
1074 stenotrophomonas maltophilia infection 9.6
1075 wallerian degeneration 9.6
1076 opioid addiction 9.6
1077 cerebral arteriosclerosis 9.6
1078 chronic pain 9.6
1079 hypersomnia 9.6
1080 myoclonus 9.6
1081 paroxysmal choreoathetosis 9.6
1082 spinal cord injury 9.6
1083 rare tumor of pancreas 9.6
1084 differentiated thyroid carcinoma 9.6
1085 jeavons syndrome 9.6
1086 inflammatory myopathy with abundant macrophages 9.6
1087 intermediate maple syrup urine disease 9.6
1088 hemolytic disease due to fetomaternal alloimmunization 9.6
1089 muscular lipidosis 9.6
1090 periodic paralysis 9.6
1091 progressive muscular dystrophy 9.6
1092 laminin subunit alpha 2-related muscular dystrophy 9.6
1093 rare hereditary hemochromatosis 9.6
1094 acute generalized exanthematous pustulosis 9.6
1095 cyanide poisoning 9.6
1096 spontaneous intracranial hypotension 9.6
1097 solid pseudopapillary carcinoma of pancreas 9.6
1098 acinar cell carcinoma of pancreas 9.6
1099 paraquat poisoning 9.6
1100 congenital portosystemic shunt 9.6
1101 gluconeogenesis disorder 9.6
1102 disorder of energy metabolism 9.6
1103 obesity due to melanocortin 4 receptor deficiency 9.6
1104 pik3ca-related overgrowth syndrome 9.6
1105 serotonin syndrome 9.6
1106 cocaine intoxication 9.6
1107 infantile epilepsy syndrome 9.6
1108 primary hypophysitis 9.6
1109 adenohypophysitis 9.6
1110 acute adrenal insufficiency 9.6
1111 streptococcal toxic-shock syndrome 9.6

Comorbidity relations with Hypoglycemia via Phenotypic Disease Network (PDN): (showing 30, show less)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Alzheimer Disease
Benign Essential Hypertension Bronchitis
Cerebral Atherosclerosis Decubitus Ulcer
Deficiency Anemia Diabetic Polyneuropathy
Encephalopathy Familial Atrial Fibrillation
First-Degree Atrioventricular Block Generalized Atherosclerosis
Heart Disease Hypertension, Essential
Hypoglycemic Coma Hypothyroidism
Intermediate Coronary Syndrome Iron Deficiency Anemia
Kidney Disease Microvascular Complications of Diabetes 1
Microvascular Complications of Diabetes 7 Mitral Valve Disease
Peripheral Vascular Disease Protein-Energy Malnutrition
Respiratory Failure Schizophreniform Disorder
Sinoatrial Node Disease Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Hypoglycemia:



Diseases related to Hypoglycemia

Symptoms & Phenotypes for Hypoglycemia

UMLS symptoms related to Hypoglycemia:


sugar craving

GenomeRNAi Phenotypes related to Hypoglycemia according to GeneCards Suite gene sharing:

26 (showing 9, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00221-A-1 9.77 AKT2 GCK INSR
2 Decreased viability GR00221-A-2 9.77 CPT2 GCK INSR
3 Decreased viability GR00221-A-3 9.77 AKT2 GCK INSR
4 Decreased viability GR00221-A-4 9.77 AKT2 CPT2 GCK INSR
5 Decreased viability GR00249-S 9.77 ACADM AGL G6PC GCG HADH
6 Decreased viability GR00301-A 9.77 AKT2
7 Decreased viability GR00342-S-3 9.77 AKT2
8 Decreased viability GR00386-A-1 9.77 ACADM AGL GCG SLC16A1
9 Decreased viability GR00402-S-2 9.77 ACADM ACADVL CPT2 GLUD1

MGI Mouse Phenotypes related to Hypoglycemia:

45 (showing 8, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.3 ABCC8 ACADM ACADVL AGL AKT2 CPT1A
2 cardiovascular system MP:0005385 10.1 ACADM ACADVL CPT1A CPT2 GCK GYS2
3 endocrine/exocrine gland MP:0005379 10.07 ABCC8 AKT2 CRH GCK GLUD1 HADH
4 adipose tissue MP:0005375 10.03 ACADVL AKT2 CRH HADH INS INSR
5 liver/biliary system MP:0005370 10.03 ACADM ACADVL AGL AKT2 CRH G6PC
6 mortality/aging MP:0010768 9.97 ACADM ACADVL AGL AKT2 CPT1A CPT2
7 muscle MP:0005369 9.56 ACADM ACADVL AGL AKT2 GYS2 INS
8 renal/urinary system MP:0005367 9.17 CRH G6PC GCK HADH INS INSR

Drugs & Therapeutics for Hypoglycemia

Drugs for Hypoglycemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 509, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
lanreotide Approved Phase 4 108736-35-2
2
Gliclazide Approved Phase 4 21187-98-4 3475
3
Linagliptin Approved Phase 4 668270-12-0 10096344
4
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
5
Racepinephrine Approved Phase 4 329-65-7 838
6
Ethanol Approved Phase 4 64-17-5 702
7
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
8
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
9
Glipizide Approved, Investigational Phase 4 29094-61-9 3478
10
Fosaprepitant Approved Phase 4 172673-20-0 219090
11
Aprepitant Approved, Investigational Phase 4 170729-80-3 6918365 151165
12
Caffeine Approved Phase 4 58-08-2 2519
13
Simvastatin Approved Phase 4 79902-63-9 54454
14
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
15
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
16
Chlorzoxazone Approved Phase 4 95-25-0 2733
17
Dextromethorphan Approved Phase 4 125-71-3 5360696 5362449
18
Tolbutamide Approved, Investigational Phase 4 64-77-7 5505
19
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
20
Bupropion Approved Phase 4 34911-55-2, 34841-39-9 444
21
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 5311068 68602
22
Haloperidol Approved Phase 4 52-86-8 3559
23
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4 439-14-5 3016
24
Esmolol Approved Phase 4 103598-03-4, 81147-92-4 59768
25
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
26
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
27
Alogliptin Approved Phase 4 850649-61-5 11450633
28
Repaglinide Approved, Investigational Phase 4 135062-02-1 65981
29
Spironolactone Approved Phase 4 52-01-7, 1952-01-7 5833
30
Glucagon Approved Phase 4 16941-32-5
31
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
32
Empagliflozin Approved Phase 4 864070-44-0